20/20 GENE SYSTEMS INC.


www.2020gene.com

20/20 GeneSystems, Inc. develops and commercializes tests that aid in the early detection and therapy selection of cancer diseases. It offers proteomics products that provide tools for protein analysis; PredicTOR, a companion diagnostic test, as well as offers L-IHC tissue analysis for multiplex biomarker analysis; and protein assay utilizing lung cancer analytes test, a blood test for the early detection of lung cancer. The company also engages in licensing its solutions. It serves drug companies, biodefense specialists, and life scientists in the United States

Solution Category
Big Data